Parameter | Complete radiological resolution on follow-up CT (n = 46; 56.8%) | Residual lung findings on follow-up CT (n = 35; 43.2%) | p value |
---|---|---|---|
Age (Mean ± SD) | 45.8 ± 13.8 | 59.6 ± 9.3 | 0.01858 |
Sex | M = 29 (63%) F = 17 (37%) | M = 21 (60%) F = 14 (40%) | 0.8205 |
BMI | |||
18–25 | 34 (74%) | 14 (40%) | 0.003 |
> 25 | 12 (26%) | 21 (60%) | |
Smoking history | |||
Smoker | 13 (28.3%) | 18 (51.4%) | 0.6497 |
Non-smoker | 33 (71.7%) | 17 (48.6%) | |
Comorbidity | |||
Absent | 26 (56.5%) | 7 (20%) | |
Present | 20 (43.5%) | 28 (80%) | |
Diabetes mellitus | 6 | 8 | |
Hypertension | 7 | 7 | |
COPD | 4 | 5 | 0.0013 |
CKD | 1 | 2 | |
CLD | 1 | 2 | |
CAD | 1 | 1 | |
Malignancy | 0 | 2 | |
Immune suppression | 0 | 1 | |
Hospitalization | |||
Inpatient | 34 (74%) | 31 (88.6%) | 0.1583 |
Outpatient | 12 (26%) | 4 (11.4%) | |
In-ward hospitalization | 43 (93.5%) | 25 (71.4%) | 0.0126 |
ICU admission | 3 (6.5%) | 10 (28.6%) | |
Duration of hospitalization | |||
(Mean days ± SD) | 7.6 ± 2.3 | 11.2 ± 4.1 | 0.000332 |
Initial percutaneous oxygen saturation (%) | |||
(Mean ± SD) | 92.3 ± 3.8 | 88.1 ± 2.2 | 0.00132 |
Initial WBC count | |||
×103 (Mean ± SD) | 5343 ± 1456.4 | 7987 ± 2465.8 | 0.00105 |
NLR | 2.5 ± 1.1 | 2.8 ± 1.3 | 0.609 |
LDH, IU/l | |||
(Mean ± SD) | 697.7 ± 198.8 | 743.8 ± 211.4 | 0.6921 |
CRP, mg/l | |||
(Mean ± SD) | 34.6 ± 17.6 | 41.1 ± 19.8 | 0.4554 |
Pharmacological treatment | |||
Antiviral drugs | 16 (34.8%) | 13 (37.1%) | 1 |
Hydroxychloroquine | 12 (26%) | 17 (48.6%) | 0.63 |
Steroids | 39 (84.8%) | 18 (51.4%) | 0.0007 |
Persistent symptoms on follow-up | 30 (65.2%) | 24 (68.5%) | 0.8148 |